CereHealth Releases An Enhanced Version of Its Imaging Platform, CereMetrixai
Using its FDA-cleared QSPECT® analysis as a template, the platform can now incorporate additional imaging, such as MRI, PET and CT, and non-imaging analytical assessments through an expanding catalog of both in-house and third-party medical image algorithms.
Micro Medical Solutions Receives FDA Breakthrough Device Designation for MicroStent Vascular Stent
This novel technology is designed to achieve and maintain vessel patency, enhance wound treatment, and improve quality of life and blood flow in order to reduce amputation and mortality for patients with critical limb-threatening ischemia (CLTI) resulting from peripheral artery disease (PAD).
Thermo Fischer Scientific Reports the Launch of the First-Ever GMP- and Cleanroom-Compatible CO2 Incubator
Thermo Fischer Scientific Heracell Vios CR CO2 Incubator expands the Thermo Scientific Cell Therapy Systems (CTS) Series laboratory equipment portfolio with a solution specifically designed for use in GMP environments.
Robocath Successfully Completes 1st Robotic Coronary Angioplasties in Belgium
These first five robotic procedures are part of a clinical study that involves six European centers.
Journal of Medical Economics Article Demonstrates Economic Benefits of Cardiovascular Systems Orbital Atherectomy in the Treatment of Peripheral Artery Disease
LIBERTY 360° represents the largest, contemporary real-world experience with various endovascular strategies across the full range of Rutherford Class (RC) patients, including those with critical limb ischemia, the most compromised RC6 patients.